One clear comparative indication is the presence of triple negative breast cancers (TNBC) (i.e. tumors that do not have receptors for estrogen or progesterone and do not produce HER2 protein), which carry the worse prognosis among breast cancer subtypes [42, 43]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.